Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

IGM Biosciences Inc

IGMS
Current price
7.24 USD -0.08 USD (-1.09%)
Last closed 7.31 USD
Company igmbio.com
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 427 330 848 USD
Yield for 12 month -22.73 %
1Y
3Y
5Y
10Y
15Y
IGMS
21.11.2021 - 28.11.2021

IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. Address: 325 East Middlefield Road, Mountain View, CA, United States, 94043

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22.56 USD

P/E ratio

Dividend Yield

Current Year

+2 130 000 USD

Last Year

+1 069 000 USD

Current Quarter

+497 000 USD

Last Quarter

+651 000 USD

Current Year

-6 146 999 USD

Last Year

+1 069 000 USD

Current Quarter

-1 679 000 USD

Last Quarter

-1 530 000 USD

Key Figures IGMS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -243 328 000 USD
Operating Margin TTM -10836.22 %
PE Ratio
Return On Assets TTM -37.57 %
PEG Ratio
Return On Equity TTM -118.26 %
Wall Street Target Price 22.56 USD
Revenue TTM 2 105 000 USD
Book Value 2.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -4.8 %
Dividend Yield
Gross Profit TTM 1 069 000 USD
Earnings per share -4.21 USD
Diluted Eps TTM -4.21 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IGMS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IGMS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IGMS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 113.293
Price Sales TTM 252.81
Enterprise Value EBITDA -0.9456
Price Book MRQ 2.6496

Financials IGMS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IGMS

For 52 weeks

3.81 USD 17.7 USD
50 Day MA 8.74 USD
Shares Short Prior Month 5 284 165
200 Day MA 8.56 USD
Short Ratio 17.46
Shares Short 5 141 840
Short Percent 35.77 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds


S

SLICHA

203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics

Metals


Gold

2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics